Cogent Biosciences (COGT) Other Working Capital Changes (2017 - 2026)

Cogent Biosciences' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$422000.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 80.57% year-over-year to -$422000.0; the TTM figure through Mar 2026 stood at $1.9 million (down 9.95% YoY), while the FY2025 annual figure was $195000.0, down 95.5% from the prior year.
• Other Working Capital Changes was -$422000.0 for Q1 2026 at Cogent Biosciences, down from $3.2 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $4.3 million in Q4 2024 to a low of -$11.8 million in Q4 2022.
• Historically, Other Working Capital Changes has averaged -$232764.7 across 5 years, with a median of $2000.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes soared 3248.48% in 2022, then tumbled 108700.0% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at -$11.8 million in 2022, then jumped by 84.33% to -$1.9 million in 2023, then soared by 334.04% to $4.3 million in 2024, then fell by 25.3% to $3.2 million in 2025, then sank by 113.04% to -$422000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$422000.0 (Q1 2026), $3.2 million (Q4 2025), and -$806000.0 (Q3 2025), per Business Quant data.